# Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria

> **NCT00004988** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 45 (—)

## Conditions studied

- Cancer
- Neoplasm
- Neoplasm Metastasis

## Interventions

- **DRUG:** VNP20009

## Key facts

- **NCT ID:** NCT00004988
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 45 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004988, "Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00004988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*